Your browser doesn't support javascript.
loading
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals.
Eybpoosh, Sana; Biglari, Alireza; Sorouri, Rahim; Ashrafian, Fatemeh; Sadat Larijani, Mona; Verez-Bencomo, Vicente; Toledo-Romani, Maria Eugenia; Valenzuela Silva, Carmen; Salehi-Vaziri, Mostafa; Dahmardeh, Sarah; Doroud, Delaram; Banifazl, Mohammad; Mostafavi, Ehsan; Bavand, Anahita; Ramezani, Amitis.
Afiliación
  • Eybpoosh S; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
  • Biglari A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sorouri R; IPI Directorate, Pasteur Institute of Iran, Tehran, Iran.
  • Ashrafian F; Department of Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Sadat Larijani M; Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
  • Verez-Bencomo V; Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
  • Toledo-Romani ME; Finlay Vaccine Institute, Havana, Cuba.
  • Valenzuela Silva C; Pedro Kourí Tropical Medicine Institute, Havana, Cuba.
  • Salehi-Vaziri M; Cybernetics, Mathematics and Physics Institute, Havana, Cuba.
  • Dahmardeh S; COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran.
  • Doroud D; Vaccination Department, Pasteur Institute of Iran, Tehran, Iran.
  • Banifazl M; Quality Control Department, Production and research Complex, Pasteur Institute of Iran, Tehran, Iran.
  • Mostafavi E; Iranian Society for Support of Patients with Infectious Disease, Tehran, Iran.
  • Bavand A; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
  • Ramezani A; Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
PLoS Pathog ; 19(11): e1011744, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37910480

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Irán